risk. The study assesses the cost-effectiveness of palivizumab versus no prophylaxis in infants at high risk of … infants at high risk of severe RSV infection who receive either prophylaxis with palivizumab or no prophylaxis. The main … environmental risk factors on the cost-effectiveness in the subgroup of preterm infants 33–35 weeks gestational age (wGA). Results …

The study explores the importance of social influence and the availability of health insurance on maternal care … utilization in Ghana through the use of antenatal care services. A number of studies have found that access to health insurance … social forces play in this decision. This study uses village-level data from the 2008 Ghana Demographic and Health Survey to …